A self-reported long-term follow-up of patients operated with either shortening techniques or a TachoSil grafting procedure

di Horstmann, Marcus, Kwol, Matthias, Amend, Bastian, Hennenlotter, Joerg, Stenzl, Arnulf
Pubblicazione 2011

Prospective evaluation of fluorescence-guided cystoscopy to detect bladder cancer in a high-risk population: results from the UroScreen-Study

di Horstmann, Marcus, Banek, Severine, Gakis, Georgios, Todenhöfer, Tilman, Aufderklamm, Stefan, Hennenlotter, Joerg, Stenzl, Arnulf, Schwentner, Christian
Pubblicazione 2014

Assessment of a new point-of-care system for detection of prostate specific antigen

di Rausch, Steffen, Hennenlotter, Joerg, Wiesenreiter, Josef, Hohneder, Andrea, Heinkele, Julian, Schwentner, Christian, Stenzl, Arnulf, Todenhöfer, Tilman
Pubblicato in BMC Urol (2016)

Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria

di Hennenlotter, Joerg, Huber, Severine, Todenhöfer, Tilman, Kuehs, Ursula, Schilling, David, Aufderklamm, Stefan, Gakis, Georgios, Schwentner, Christian, Stenzl, Arnulf
Pubblicazione 2011

Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma

di Todenhöfer, Tilman, Wirths, Stefan, von Weyhern, Claus Hann, Heckl, Stefan, Horger, Marius, Hennenlotter, Joerg, Stenzl, Arnulf, Kanz, Lothar, Schwentner, Christian
Pubblicazione 2012

Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma

di von Klot, Christoph-A, Kramer, Mario W, Peters, Inga, Hennenlotter, Joerg, Abbas, Mahmoud, Scherer, Ralph, Herrmann, Thomas RW, Stenzl, Arnulf, Kuczyk, Markus A, Serth, Juergen, Merseburger, Axel S
Pubblicazione 2014

HYAL-1 Hyaluronidase: A Potential Prognostic Indicator for Progression to Muscle Invasion and Recurrence in Bladder Cancer

di Kramer, Mario W., Golshani, Roozbeh, Merseburger, Axel S., Knapp, Judith, Garcia, Alfredo, Hennenlotter, Joerg, Duncan, Robert C., Soloway, Mark S., Jorda, Merce, Kuczyk, Marcus A., Stenzl, Arnulf, Lokeshwar, Vinata B
Pubblicazione 2009

Immunocytology Is Strong Predictor of Bladder Cancer Presence in Patients With Painless Hematuria: A Multicentre Study

di Cha, Eugene K., Tirsar, Lenuta-Ancuta, Schwentner, Christian, Christos, Paul J., Mian, Christine, Hennenlotter, Joerg, Martini, Thomas, Stenzl, Arnulf, Pycha, Armin, Shariat, Shahrokh F., Schmitz-Dräger, Bernd J.
Pubblicazione 2011

GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma

di PETERS, INGA, GEBAUER, KAI, DUBROWINSKAJA, NATALIA, ATSCHEKZEI, FARANAZ, KRAMER, MARIO W., HENNENLOTTER, JOERG, TEZVAL, HOSSEIN, ABBAS, MAHMOUD, SCHERER, RALPH, MERSEBURGER, AXEL S., STENZL, ARNULF, KUCZYK, MARKUS A., SERTH, JUERGEN
Pubblicazione 2014

Accurate Risk Assessment of Patients with Asymptomatic Hematuria for the Presence of Bladder Cancer

di Cha, Eugene K., Tirsar, Lenuta-Ancuta, Schwentner, Christian, Hennenlotter, Joerg, Christos, Paul J., Stenzl, Arnulf, Mian, Christine, Martini, Thomas, Pycha, Armin, Shariat, Shahrokh F., Schmitz-Dräger, Bernd J.
Pubblicazione 2012